As of 2025-03-19, the Relative Valuation of Royalty Pharma PLC (RPRX) is 33.42 USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.41 USD, the upside of Royalty Pharma PLC based on Relative Valuation is 0.0%.
The range of the Relative Valuation is 31.11 - 37.79 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 24.7x | 22.4x |
| Forward P/E multiples | 18.7x - 21.3x | 18.9x |
| Fair Price | 31.11 - 37.79 | 33.42 |
| Upside | -6.9% - 13.1% | 0.0% |
| Date | P/E |
| 2025-03-19 | 22.43 |
| 2025-03-18 | 22.42 |
| 2025-03-17 | 22.16 |
| 2025-03-14 | 21.99 |
| 2025-03-13 | 21.93 |
| 2025-03-12 | 22.05 |
| 2025-03-11 | 21.78 |
| 2025-03-10 | 21.98 |
| 2025-03-07 | 22.15 |
| 2025-03-06 | 22.33 |
| 2025-03-05 | 22.66 |
| 2025-03-04 | 22.36 |
| 2025-03-03 | 22.72 |
| 2025-02-28 | 22.58 |
| 2025-02-27 | 22.39 |
| 2025-02-26 | 22.40 |
| 2025-02-25 | 22.61 |
| 2025-02-24 | 22.68 |
| 2025-02-21 | 22.43 |
| 2025-02-20 | 22.37 |
| 2025-02-19 | 21.87 |
| 2025-02-18 | 22.05 |
| 2025-02-14 | 21.72 |
| 2025-02-13 | 21.78 |
| 2025-02-12 | 21.70 |
| 2025-02-11 | 21.64 |
| 2025-02-10 | 21.29 |
| 2025-02-07 | 21.29 |
| 2025-02-06 | 21.07 |
| 2025-02-05 | 21.11 |
| 2025-02-04 | 20.98 |
| 2025-02-03 | 21.03 |
| 2025-01-31 | 21.19 |
| 2025-01-30 | 21.20 |
| 2025-01-29 | 21.44 |
| 2025-01-28 | 21.43 |
| 2025-01-27 | 21.29 |
| 2025-01-24 | 20.84 |
| 2025-01-23 | 20.55 |
| 2025-01-22 | 20.19 |
| 2025-01-21 | 20.33 |
| 2025-01-17 | 20.64 |
| 2025-01-16 | 20.77 |
| 2025-01-15 | 20.63 |
| 2025-01-14 | 20.15 |
| 2025-01-13 | 20.13 |
| 2025-01-10 | 19.79 |
| 2025-01-08 | 17.58 |
| 2025-01-07 | 17.48 |
| 2025-01-06 | 17.28 |